U-Neuron Biomedical's intangible assets is $2.2M.
Get informed when a big investor buys or sells
+ FollowLatest change versus the prior comparable period (same company).
U-Neuron Biomedical's intangible assets stands at $2.2M as of June 2026. That compares with $2.2M in the prior-year period — up 0.0% year over year. Stockcircle updates this page with the newest filings so you can track how the metric evolves quarter by quarter.
U-Neuron Biomedical reported $2.2M in intangible assets versus $2.2M a year earlier — essentially flat versus a year earlier. The historical chart on this page makes it easier to see whether that move is part of a longer pattern.
That compares with $2.2M in the prior-year period — up 0.0% year over year. Sustained growth in intangible assets can support a stronger franchise, while sharp declines may reflect divestitures, weaker demand, or accounting changes. Always read YoY moves with the footnotes of recent filings in mind.
The history chart shows how U-Neuron Biomedical's intangible assets evolved across reporting periods, while the comparison chart places 6973.TWO next to similar companies. Use both: a rising metric that still lags peers tells a different story than a rising metric that already leads the group. Growth charts, when available, highlight acceleration or slowdown.
Yes — within Healthcare, intangible assets is commonly used to spot outliers. U-Neuron Biomedical's reading of $2.2M is a starting point; confirm whether differences come from growth, margins, accounting choices, or one-time items before treating an outlier as a buy or sell signal.